Negotiating the Commercial Cliff March, 18th  | Princeton, NJ

At The Westin Princeton at Forrestal Village

In a highly dynamic market environment, pharmaceutical companies are grappling with challenges as they relate to evolving technology and cloud-based solutions in customer engagement, dealing with big data to customize customer experience and driving standardization, global compliance, and commercial effectiveness.

PHARMAFUTURE ™  2016 will focus on the views of the captains of the industry about how external market dynamics are redefining the way companies organize themselves to remain competitive and drive commercial growth.

Welcome Note : Indegene

15:00-15:15

Key Note:

Jay Galeota

Chief Strategy & Business Development Officer/ President - Emerging Businesses, Merck & Co., Inc.


"Navigating the Path to the Future Growth of the Industry" - Are commercial leaders prepared for the era of personalized medicine and value based healthcare?"

15:15-15:55

Panel Discussion I : External Transformation

Dana Rodden

Head, Multichannel Marketing Strategy & Operations, GlaxoSmithKline

Theo Nieuwenhuis

Corporate Senior Vice President – Head of Corporate Commercial Operations, Boehringer Ingelheim

David Lennon

VP & Franchise Head, US Oncology, Novartis

Robert Gargiulo

Director of Integrated Marketing, Specialty Brands, Mylan Pharmaceuticals


Moderators :

Bob Glaser

Chief Marketing & Sales Officer, Indegene Inc.

Rob Charasidis

Multi-Channel Marketing - North America & Europe, Indegene Inc.

15:55-16:35

Coffee Break

16:35-16:50

Panel Discussion II : Internal Transformation

Tara Stewart

Worldwide Multi-Channel Marketing Hub Head, Bristol-Myers Squibb

Kevin Guerette

Executive Director Global Commercial Operations, AstraZeneca

Sandra Velez

Content Strategy Leader, Merck & Co., Inc.

Michael Townsend

Research Manager, Life Science Business System Strategies, International Data Corporation


Moderators :

Marc A Valdiviezo

VP Multi-Channel Marketing (MCM), Indegene Inc.

Vivek Ghai

SVP, Indegene Inc.

16:50-17:30

Closing Remarks : Indegene

17:30-17:45

Cocktails and Networking

17:45 onwards

KeyNote Session

Jay Galeota

Chief Strategy & Business Development Officer/ President - Emerging Businesses, Merck & Co., Inc.

Panelists

Dana Rodden

Head, Multichannel Marketing Strategy & Operations, GlaxoSmithKline

Michael Townsend

Research Manager, Life Science Business System Strategies, International Data Corporation

Tara Stewart

Worldwide Multi-Channel Marketing Hub Head, Bristol-Myers Squibb

Theo Nieuwenhuis

Corporate Senior Vice President – Head of Corporate Commercial Operations, Boehringer Ingelheim

David Lennon

VP & Franchise Head, US Oncology, Novartis

Robert Gargiulo

Director of Integrated Marketing, Specialty Brands, Mylan Pharmaceuticals

Kevin Guerette

Executive Director Global Commercial Operations, AstraZeneca

Sandra Velez

Content Strategy Leader, Merck & Co., Inc.

About  PHARMAFUTURE ™ 

PHARMAFUTURE ™  (www.pharmafuture.org) is a global thought leadership forum for senior pharmaceutical executives. Its objective is to bring together senior leaders of the industry in an interactive setting to discuss the key challenges the industry faces, share experiences, and brainstorm ideas and solutions to drive better health and business outcomes.

Over the last 3 years, PHARMAFUTURE ™  has become a highly regarded platform for an open and thought-provoking exchange of views among people who are entrusted with the key strategic decisions within the pharmaceutical industry.

PHARMAFUTURE ™  is an initiative of Indegene – a leading global health-care solutions company that integrates medical/pharmaceutical expertise, technology, analytics, and operational excellence to address some of the major challenges in the industry.

PHARMAFUTURE ™

Senior Executives
Pharma
Global Chapters

Highly engaging platform with an opportunity to network with visionaries. The sessions touched upon areas that can be truly impactful if implemented in the right manner.

- Vice President Marketing, Top 5 Pharma at  PHARMAFUTURE ™ 2014, Shanghai